03 Sep 2008

Inhaled Treprostinil New Drug Application Filed by FDA

SILVER SPRING, Md., Sept. 3 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary Lung Rx, Inc. announced today that the U.S. Food and Drug...

Download pdf

31 Jul 2008

United Therapeutics Reports Second Quarter 2008 Financial Results

SILVER SPRING, Md., July 31 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended June 30, 2008. Total revenues...

Download pdf

24 Jul 2008

United Therapeutics to Announce Second Quarter 2008 Financial Results Before Market Open on Thursday, July 31, 2008

SILVER SPRING, Md., July 24 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2008 second quarter financial results before the open of...

Download pdf

30 Jun 2008

New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration

SILVER SPRING, Md., June 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary, Lung Rx, Inc., announced today the submission of a New Drug...

Download pdf

21 May 2008

Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration

SILVER SPRING, Md., May 21 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary Lung Rx, Inc. today announced that data from seven presentations...

Download pdf

06 May 2008

Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society

SILVER SPRING, Md., May 6 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and its wholly-owned subsidiary Lung Rx, Inc. today announced that data related to the four...

Download pdf

01 May 2008

United Therapeutics Announces the Results of Its 2008 Annual Meeting of Shareholders

SILVER SPRING, Md., May 1 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) (the Company) held its annual meeting of shareholders (the Annual Meeting) on April 29, 2008. The...

Download pdf

01 May 2008

United Therapeutics Reports First Quarter 2008 Financial Results

SILVER SPRING, Md., May 1 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended March 31, 2008. Total revenues...

Download pdf

24 Apr 2008

United Therapeutics to Announce First Quarter 2008 Financial Results Before Market Open on Thursday, May 1, 2008

SILVER SPRING, Md., April 24 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2008 first quarter financial results before the open of...

Download pdf

19 Feb 2008

United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results

SILVER SPRING, Md., Feb. 19 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced financial results for the fourth quarter and year ended December 31, 2007. "We...

Download pdf

12 Feb 2008

United Therapeutics to Announce Fourth Quarter and Annual 2007 Financial Results Before Market Open on Tuesday, February 19, 2008

SILVER SPRING, Md., Feb. 12 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2007 fourth quarter and annual financial results before...

Download pdf

05 Dec 2007

Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint

SILVER SPRING, Md. and WELLESLEY HILLS, Mass., Dec. 5 /PRNewswire- FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and its wholly- owned subsidiary, Unither Pharmaceuticals, Inc...

Download pdf